documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
940 rows where docket_id = "FDA-2024-N-5471" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, last_modified, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-N-5471-4278 | FDA | None FDA-2024-N-5471 | Request for Four-Month Extension of Comment Period from JTI LIGGETT LLC | Other | Request for Extension | 2025-10-01T04:00:00Z | 2025 | 10 | 2025-10-01T04:00:00Z | 2025-10-01T21:10:08Z | 0 | 0 | 09000064b8f1fda7 | ||
| FDA-2024-N-5471-0935 | FDA | None FDA-2024-N-5471 | TAB A - Nicotine PRIA as Submitted to OMB | Supporting & Related Material | Background Material | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:40Z | 0 | 0 | 09000064868cd8a6 | |||
| FDA-2024-N-5471-0936 | FDA | None FDA-2024-N-5471 | TAB B - Nicotine NPRM Track Changes | Supporting & Related Material | Background Material | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:40Z | 0 | 0 | 09000064868cd8a7 | |||
| FDA-2024-N-5471-0938 | FDA | None FDA-2024-N-5471 | TAB C - Nicotine NPRM as Cleared by OMB | Supporting & Related Material | Background Material | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:40Z | 0 | 0 | 09000064868cddb8 | |||
| FDA-2024-N-5471-0937 | FDA | None FDA-2024-N-5471 | TAB B - Nicotine PRIA Track Changes | Supporting & Related Material | Background Material | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:40Z | 0 | 0 | 09000064868cd8a8 | |||
| FDA-2024-N-5471-0933 | FDA | None FDA-2024-N-5471 | Memo to FDA DMB re Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products (Proposed Rule) | Other | Memorandum | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-01-17T05:00:00Z | 2025-06-06T20:24:40Z | 0 | 0 | 09000064868cd752 | ||
| FDA-2024-N-5471-0934 | FDA | None FDA-2024-N-5471 | TAB A - Nicotine NPRM as Submitted to OMB | Supporting & Related Material | Background Material | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:40Z | 0 | 0 | 09000064868cd8a5 | |||
| FDA-2024-N-5471-0939 | FDA | None FDA-2024-N-5471 | TAB C - Nicotine PRIA as Cleared by OMB | Supporting & Related Material | Background Material | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:40Z | 0 | 0 | 09000064868cddbe | |||
| FDA-2024-N-5471-0004 | FDA | None FDA-2024-N-5471 | Reference 2 - Brown William Letter from RB Griffith 1963 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:16Z | 0 | 0 | 090000648689966a | |||
| FDA-2024-N-5471-0009 | FDA | None FDA-2024-N-5471 | Reference 7 - FDA Hookah Tobacco Shisha or Waterpipe 2023 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:17Z | 0 | 0 | 090000648689966f | |||
| FDA-2024-N-5471-0013 | FDA | None FDA-2024-N-5471 | Reference 11 - Max Deaths from secondhand smoke exposure 2012 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:17Z | 0 | 0 | 0900006486899bdd | |||
| FDA-2024-N-5471-0039 | FDA | None FDA-2024-N-5471 | Reference 37 - Chaiton Estimating the number of quit 2016 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:18Z | 0 | 0 | 0900006486899cbf | |||
| FDA-2024-N-5471-0120 | FDA | None FDA-2024-N-5471 | Reference 118 - Ellis Racial and Ethnic Disparities 2018 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:19Z | 0 | 0 | 0900006486899e36 | |||
| FDA-2024-N-5471-0128 | FDA | None FDA-2024-N-5471 | Reference 126 - Vurbic Cooccurring obesity and smoking 2015 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:19Z | 0 | 0 | 0900006486899e3e | |||
| FDA-2024-N-5471-0217 | FDA | None FDA-2024-N-5471 | Reference 215 Chen Sankey Real Time Context of Tobacco 2022 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:20Z | 0 | 0 | 090000648689a066 | |||
| FDA-2024-N-5471-0056 | FDA | None FDA-2024-N-5471 | Reference 54 - McDonald Deposition of cigar smoke particles 2002 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:21Z | 0 | 0 | 090000648689a14a | |||
| FDA-2024-N-5471-0066 | FDA | None FDA-2024-N-5471 | Reference 64 - Donny Smoking in the absence of nicotine 2007 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:21Z | 0 | 0 | 090000648689a161 | |||
| FDA-2024-N-5471-0088 | FDA | None FDA-2024-N-5471 | Reference 86 - Substance Abuse Key substance use and mental 2024 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:22Z | 0 | 0 | 090000648689a177 | |||
| FDA-2024-N-5471-0166 | FDA | None FDA-2024-N-5471 | Reference 164 - Baker Health risks associated with cigar 2000 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:22Z | 0 | 0 | 090000648689a89d | |||
| FDA-2024-N-5471-0171 | FDA | None FDA-2024-N-5471 | Reference 169 - Inoue Choi Contemporary Associations 2019 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:22Z | 0 | 0 | 090000648689a8a2 | |||
| FDA-2024-N-5471-0185 | FDA | None FDA-2024-N-5471 | Reference 183 - Primack Volume of tobacco advertising 2007 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:23Z | 0 | 0 | 090000648689a8b4 | |||
| FDA-2024-N-5471-0199 | FDA | None FDA-2024-N-5471 | Reference 197 - Apollonio Marketing to the marginalised 2005 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:23Z | 0 | 0 | 090000648689a8cc | |||
| FDA-2024-N-5471-0010 | FDA | None FDA-2024-N-5471 | Reference 8 - National Academies Public health consequence 2018 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:17Z | 0 | 0 | 0900006486899bef | |||
| FDA-2024-N-5471-0016 | FDA | None FDA-2024-N-5471 | Reference 14 - Mendez Monitoring the Increase in the U.S 2022 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:17Z | 0 | 0 | 0900006486899ca5 | |||
| FDA-2024-N-5471-0024 | FDA | None FDA-2024-N-5471 | Reference 22 - Kann Youth risk behavior surveillance 2016 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:17Z | 0 | 0 | 0900006486899cad | |||
| FDA-2024-N-5471-0042 | FDA | None FDA-2024-N-5471 | Reference 40 - Benowitz Nicotine and carcinogen exposure 2007 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:18Z | 0 | 0 | 0900006486899cc2 | |||
| FDA-2024-N-5471-0094 | FDA | None FDA-2024-N-5471 | Reference 92 - Sargent Adolescent smoking experimentation 2017 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:18Z | 0 | 0 | 0900006486899d95 | |||
| FDA-2024-N-5471-0119 | FDA | None FDA-2024-N-5471 | Reference 117 - Howe Indirect method to estimate specific 2009 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:19Z | 0 | 0 | 0900006486899e35 | |||
| FDA-2024-N-5471-0125 | FDA | None FDA-2024-N-5471 | Reference 123 - HHS Tobacco Use Among US Racial ethnic 1998 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:19Z | 0 | 0 | 0900006486899e3b | |||
| FDA-2024-N-5471-0131 | FDA | None FDA-2024-N-5471 | Reference 129 - Stanton Trends in tobacco use among US 2016 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:19Z | 0 | 0 | 0900006486899e41 | |||
| FDA-2024-N-5471-0153 | FDA | None FDA-2024-N-5471 | Reference 151 - Arku Seasonal variability in environmental 2015 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:20Z | 0 | 0 | 0900006486899e5a | |||
| FDA-2024-N-5471-0207 | FDA | None FDA-2024-N-5471 | Reference 205 Yerger What more evidence is needed 2022 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:20Z | 0 | 0 | 090000648689a04f | |||
| FDA-2024-N-5471-0210 | FDA | None FDA-2024-N-5471 | Reference 208 Gunther Presumed influence on peer norms 2006 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:20Z | 0 | 0 | 090000648689a052 | |||
| FDA-2024-N-5471-0223 | FDA | None FDA-2024-N-5471 | Reference 221 Nicksic Smoking status and racial ethnic 2022 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:20Z | 0 | 0 | 090000648689a06c | |||
| FDA-2024-N-5471-0170 | FDA | None FDA-2024-N-5471 | Reference 168 - Christensen Association of cigarette 2018 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:22Z | 0 | 0 | 090000648689a8a1 | |||
| FDA-2024-N-5471-0172 | FDA | None FDA-2024-N-5471 | Reference 170 - Eichner Tobacco use and cardiovascular 2010 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:22Z | 0 | 0 | 090000648689a8a3 | |||
| FDA-2024-N-5471-0182 | FDA | None FDA-2024-N-5471 | Reference 180 - Carroll Tobacco Industry Marketing Exposure 2020 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:23Z | 0 | 0 | 090000648689a8ad | |||
| FDA-2024-N-5471-0195 | FDA | None FDA-2024-N-5471 | Reference 193 - Marsh Association between density 2021 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:23Z | 0 | 0 | 090000648689a8c8 | |||
| FDA-2024-N-5471-0145 | FDA | None FDA-2024-N-5471 | Reference 143 - Cochran Sexual orientation related 2013 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:19Z | 0 | 0 | 0900006486899e52 | |||
| FDA-2024-N-5471-0226 | FDA | None FDA-2024-N-5471 | Reference 224 Soneji Online tobacco marketing among US 2019 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:20Z | 0 | 0 | 090000648689a06f | |||
| FDA-2024-N-5471-0239 | FDA | None FDA-2024-N-5471 | Reference 237 Kaufman Food and Drug Administration Evaluation 2011 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:21Z | 0 | 0 | 090000648689a07c | |||
| FDA-2024-N-5471-0247 | FDA | None FDA-2024-N-5471 | Reference 245 Weiger Beliefs and Characteristics Associated 2022 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:21Z | 0 | 0 | 090000648689a084 | |||
| FDA-2024-N-5471-0057 | FDA | None FDA-2024-N-5471 | Reference 55 - Rodriguez The association of pipe and 2010 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:21Z | 0 | 0 | 090000648689a14b | |||
| FDA-2024-N-5471-0067 | FDA | None FDA-2024-N-5471 | Reference 65 - Walker Longitudinal examination of predictors 2014 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:21Z | 0 | 0 | 090000648689a162 | |||
| FDA-2024-N-5471-0113 | FDA | None FDA-2024-N-5471 | Reference 111 - Pulvers Light and intermittent smoking 2015 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:22Z | 0 | 0 | 090000648689a508 | |||
| FDA-2024-N-5471-0164 | FDA | None FDA-2024-N-5471 | Reference 162 - HHS Reducing the health consequences of 1989 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:22Z | 0 | 0 | 090000648689a89b | |||
| FDA-2024-N-5471-0450 | FDA | None FDA-2024-N-5471 | Reference 448 - Rose Psychopharmacological interactions 2004 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:31Z | 0 | 0 | 090000648689d3d2 | |||
| FDA-2024-N-5471-0642 | FDA | None FDA-2024-N-5471 | Reference 640 Pappas Cadmium lead and thallium in smoke 2007 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:32Z | 0 | 0 | 090000648689d555 | |||
| FDA-2024-N-5471-0613 | FDA | None FDA-2024-N-5471 | Reference 611 Faulkner Neural basis of smoking induced 2019 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:32Z | 0 | 0 | 090000648689db17 | |||
| FDA-2024-N-5471-0617 | FDA | None FDA-2024-N-5471 | Reference 615 Parker Effect of brief nicotine corrective 2022 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:33Z | 0 | 0 | 090000648689db1b | |||
| FDA-2024-N-5471-0621 | FDA | None FDA-2024-N-5471 | Reference 619 Pacek Knowledge about nicotine among HIV 2017 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:33Z | 0 | 0 | 090000648689db1f | |||
| FDA-2024-N-5471-0629 | FDA | None FDA-2024-N-5471 | Reference 627 Marshall Evaluation of smoking characteristics 2008 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:33Z | 0 | 0 | 090000648689db27 | |||
| FDA-2024-N-5471-0712 | FDA | None FDA-2024-N-5471 | PRIA Reference 43 National Center for Health Statistics Public Use Linked Mortality Files 2019 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:34Z | 0 | 0 | 09000064868a5b12 | |||
| FDA-2024-N-5471-0724 | FDA | None FDA-2024-N-5471 | PRIA Reference 55 US Department of Health and Human Services Eliminating Tobacco Related Disease and Death 2024 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:34Z | 0 | 0 | 09000064868a5b2c | |||
| FDA-2024-N-5471-0730 | FDA | None FDA-2024-N-5471 | PRIA Reference 61 Thun Smoking vs Other Risk Factors as the Cause of Smoking Attributable Deaths 2000 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:35Z | 0 | 0 | 09000064868a5b32 | |||
| FDA-2024-N-5471-0722 | FDA | None FDA-2024-N-5471 | PRIA Reference 53 US Food and Drug Administration Tobacco User Fee Assessment Formulation by Product Class 2022 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:34Z | 0 | 0 | 09000064868a5b2a | |||
| FDA-2024-N-5471-0740 | FDA | None FDA-2024-N-5471 | PRIA Reference 71 Bolnick Health Care Spending Attributable to Modifiable Risk Factors 2020 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:35Z | 0 | 0 | 09000064868a5b3c | |||
| FDA-2024-N-5471-0763 | FDA | None FDA-2024-N-5471 | PRIA Reference 94 Gong Whats in a butt environmental contamination 2017 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:37Z | 0 | 0 | 09000064868a5f29 | |||
| FDA-2024-N-5471-0768 | FDA | None FDA-2024-N-5471 | PRIA Reference 99 Wu Smoking Cessation and Changes in Anxiety and Depression 2023 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:37Z | 0 | 0 | 09000064868a5f2e | |||
| FDA-2024-N-5471-0781 | FDA | None FDA-2024-N-5471 | PRIA Reference 112 RTI Reformulation Cost Model 2015 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:37Z | 0 | 0 | 09000064868a5f99 | |||
| FDA-2024-N-5471-0794 | FDA | None FDA-2024-N-5471 | PRIA Reference 125 US Department of Health and Human Services Commonly Used Drugs Charts 2020 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:37Z | 0 | 0 | 09000064868a5fa6 | |||
| FDA-2024-N-5471-0823 | FDA | None FDA-2024-N-5471 | PRIA Reference 154 Denlinger Apte Low Nicotine Content Descriptors Reduce Perceived Health Risks 2017 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:38Z | 0 | 0 | 09000064868a600b | |||
| FDA-2024-N-5471-0825 | FDA | None FDA-2024-N-5471 | PRIA Reference 156 Perkins The Influence of Instructions and Nicotine Dose 2004 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:38Z | 0 | 0 | 09000064868a600d | |||
| FDA-2024-N-5471-0439 | FDA | None FDA-2024-N-5471 | Reference 437 - Perkins Acute negative affect relief from 2010 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:31Z | 0 | 0 | 090000648689d3c7 | |||
| FDA-2024-N-5471-0443 | FDA | None FDA-2024-N-5471 | Reference 441 - Carter Principles of laboratory 2009 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:31Z | 0 | 0 | 090000648689d3cb | |||
| FDA-2024-N-5471-0842 | FDA | None FDA-2024-N-5471 | PRIA Reference 173 Soneji Transitions in Frequency of Hookah Smoking 2021 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:35Z | 0 | 0 | 09000064868a5bbb | |||
| FDA-2024-N-5471-0696 | FDA | None FDA-2024-N-5471 | PRIA Reference 27 - Shastri Disparities in Secondhand Smoke Exposure in the United States 2021 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:34Z | 0 | 0 | 09000064868a5b02 | |||
| FDA-2024-N-5471-0703 | FDA | None FDA-2024-N-5471 | PRIA Reference 34 - Jamal Tobacco Use Among Middle and High School Students 2017 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:34Z | 0 | 0 | 09000064868a5b09 | |||
| FDA-2024-N-5471-0714 | FDA | None FDA-2024-N-5471 | PRIA Reference 45 Euromonitor International Assessing the US Market for Cigars and Cigarillos 2021 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:34Z | 0 | 0 | 09000064868a5b22 | |||
| FDA-2024-N-5471-0873 | FDA | None FDA-2024-N-5471 | PRIA Reference 204 Lee Inequalities in Tobacco Outlet Density 2017 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:36Z | 0 | 0 | 09000064868a5c2d | |||
| FDA-2024-N-5471-0769 | FDA | None FDA-2024-N-5471 | PRIA Reference 100 US Census Bureau Annual Capital Expenditures Survey 2024 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:37Z | 0 | 0 | 09000064868a5f2f | |||
| FDA-2024-N-5471-0786 | FDA | None FDA-2024-N-5471 | PRIA Reference 117 Piasecki Smoking Withdrawal Dynamics in Unaided Quitters 2000 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:37Z | 0 | 0 | 09000064868a5f9e | |||
| FDA-2024-N-5471-0799 | FDA | None FDA-2024-N-5471 | PRIA Reference 130 Kandel On the Development of Nicotine Dependence in Adolescence 2007 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:37Z | 0 | 0 | 09000064868a5fab | |||
| FDA-2024-N-5471-0802 | FDA | None FDA-2024-N-5471 | PRIA Reference 133 Substance Abuse and Mental Health Services Administration Key Substance Use and Mental Health Indicators 2020 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:37Z | 0 | 0 | 09000064868a5fae | |||
| FDA-2024-N-5471-0810 | FDA | None FDA-2024-N-5471 | PRIA Reference 141 Cawley The Demand for Cigarettes as Derived from the Demand for Weight Loss 2016 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:38Z | 0 | 0 | 09000064868a5fb6 | |||
| FDA-2024-N-5471-0437 | FDA | None FDA-2024-N-5471 | Reference 435 - Perkins Sex differences in the influence 2006 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:31Z | 0 | 0 | 090000648689d3c5 | |||
| FDA-2024-N-5471-0444 | FDA | None FDA-2024-N-5471 | Reference 442 - Cassidy Adolescent smokers response to 2018 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:31Z | 0 | 0 | 090000648689d3cc | |||
| FDA-2024-N-5471-0638 | FDA | None FDA-2024-N-5471 | Reference 636 Lin Effect of menthol on nicotine reduction 2022 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:32Z | 0 | 0 | 090000648689d551 | |||
| FDA-2024-N-5471-0646 | FDA | None FDA-2024-N-5471 | Reference 644 Creamer Tobacco Product Use and Cessation 2019 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:32Z | 0 | 0 | 090000648689d559 | |||
| FDA-2024-N-5471-0607 | FDA | None FDA-2024-N-5471 | Reference 605 Song Reduction and cessation of cigarette 2008 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:32Z | 0 | 0 | 090000648689db11 | |||
| FDA-2024-N-5471-0877 | FDA | None FDA-2024-N-5471 | PRIA Reference 208 Dsilva Tobacco Industry Misappropriation of American Indian Culture and Traditional Tobacco 2018 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:36Z | 0 | 0 | 09000064868a5c31 | |||
| FDA-2024-N-5471-0886 | FDA | None FDA-2024-N-5471 | PRIA Reference 217 Dai The Prevalence of Exposure to Workplace Secondhand Smoke 2017 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:36Z | 0 | 0 | 09000064868a5c3a | |||
| FDA-2024-N-5471-0758 | FDA | None FDA-2024-N-5471 | PRIA Reference 89 Moerman Analysis of Metals Leached from Smoked Cigarette Litter 2011 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:36Z | 0 | 0 | 09000064868a5f24 | |||
| FDA-2024-N-5471-0772 | FDA | None FDA-2024-N-5471 | PRIA Reference 103 Davis Recessions and the Costs of Job Loss 2011 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:37Z | 0 | 0 | 09000064868a5f32 | |||
| FDA-2024-N-5471-0542 | FDA | None FDA-2024-N-5471 | Reference 540 Chen Toxicological analysis of low 2008 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:29Z | 0 | 0 | 090000648689d0ba | |||
| FDA-2024-N-5471-0546 | FDA | None FDA-2024-N-5471 | Reference 544 Doll Mortality from cancer in relation to 2005 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:29Z | 0 | 0 | 090000648689d0be | |||
| FDA-2024-N-5471-0547 | FDA | None FDA-2024-N-5471 | Reference 545 National Center Public Use Linked Mortality 2019 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:29Z | 0 | 0 | 090000648689d0bf | |||
| FDA-2024-N-5471-0557 | FDA | None FDA-2024-N-5471 | Reference 555 Jacobsen Effects of smoking and smoking 2005 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:30Z | 0 | 0 | 090000648689d0c9 | |||
| FDA-2024-N-5471-0567 | FDA | None FDA-2024-N-5471 | Reference 565 Jia Trends in quality adjusted life years 2010 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:30Z | 0 | 0 | 090000648689d0d3 | |||
| FDA-2024-N-5471-0570 | FDA | None FDA-2024-N-5471 | Reference 568 World Health Organization Tobacco Health Benefits 2020 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:30Z | 0 | 0 | 090000648689d0d6 | |||
| FDA-2024-N-5471-0453 | FDA | None FDA-2024-N-5471 | Reference 451 - Darredeau The effects of nicotine content 2013 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:31Z | 0 | 0 | 090000648689d3d5 | |||
| FDA-2024-N-5471-0611 | FDA | None FDA-2024-N-5471 | Reference 609 White Early Changes in Puffing Intensity 2022 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:32Z | 0 | 0 | 090000648689db15 | |||
| FDA-2024-N-5471-0640 | FDA | None FDA-2024-N-5471 | Reference 638 Pacek Evaluation of a reduced nicotine 2016 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:32Z | 0 | 0 | 090000648689d553 | |||
| FDA-2024-N-5471-0623 | FDA | None FDA-2024-N-5471 | Reference 621 Cassidy Age Moderates Smokers Subjective 2018 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:33Z | 0 | 0 | 090000648689db21 | |||
| FDA-2024-N-5471-0676 | FDA | None FDA-2024-N-5471 | PRIA Reference 7 US Department of Health and Human Services The Health Consequences of Smoking Nicotine Addiction 1988 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:33Z | 0 | 0 | 09000064868a5ad6 | |||
| FDA-2024-N-5471-0680 | FDA | None FDA-2024-N-5471 | PRIA Reference 11 - Hatsukami Reduced nicotine content cigarettes effects on toxicant exposure 2010 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:33Z | 0 | 0 | 09000064868a5ada | |||
| FDA-2024-N-5471-0685 | FDA | None FDA-2024-N-5471 | PRIA Reference 16 - Gruber Is Addictional Rational 2001 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:34Z | 0 | 0 | 09000064868a5adf | |||
| FDA-2024-N-5471-0852 | FDA | None FDA-2024-N-5471 | PRIA Reference 183 Safford Association of Race and Sex with Risk of Incident Acute Coronary Heart Disease 2012 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:35Z | 0 | 0 | 09000064868a5bc5 | |||
| FDA-2024-N-5471-0878 | FDA | None FDA-2024-N-5471 | PRIA Reference 209 National Cancer Institute The Role of the Media in Promoting and Reducing Tobacco Use 2008 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:36Z | 0 | 0 | 09000064868a5c32 | |||
| FDA-2024-N-5471-0780 | FDA | None FDA-2024-N-5471 | PRIA Reference 111 Just Welfare Economics of Public Policy 2004 | Supporting & Related Material | Background Material | 2025-01-16T05:00:00Z | 2025 | 1 | 2025-06-06T20:24:37Z | 0 | 0 | 09000064868a5f98 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;